The relationship between malaria-related outcomes and cytokine production in whole blood cultures associated with cellular immune responses and immunity to Plasmodium falciparum malaria was examined in a study in southern Ghana. Production of malaria-specific interferon (IFN)-g was associated with reduced risk of fever and clinical malaria. Protective IFN-g responses were induced by live schizonts but not by dead parasites. Production of malaria-specific tumor necrosis factor (TNF)-a was associated with reduced risk of fever during follow-up. Baseline levels of TNF-a and phytohemagglutinin (PHA)-induced interleukin (IL)-10 were positively associated with hemoglobin concentration. IL-12 production was associated with reduced risk of parasitemia. PHA-induced transforming growth factor-b production was associated with reduced risk of fever during follow-up. High ratios of proinflammatory to anti-inflammatory cytokines were associated with increased risk of fever and higher hemoglobin concentrations. Thus, absolute levels and ratios of proinflammatory and anti-inflammatory cytokines influence susceptibility to infection, clinical disease, and anemia. These data contradict data from cross-sectional clinical studies and indicate a need for detailed analysis of the relationship between cellular immunity to malaria and resistance to disease.
Clinical immunity to malaria is characterized by the ability to control parasite replication in such a way that peripheral parasitemia remains below the critical threshold for induction of symptoms and by the ability to regulate either the production or the downstream effects of endogenous pyrogens (e.g., interleukin [IL]-1, IL-6, and tumor necrosis factor [TNF]-a) that mediate much of the pathology associated with malarial infection [1] . Because monokines and lymphokines are also crucial to induction of immune effector mechanisms, the outcome of infection appears to hinge on a delicate balance between appropriate and inappropriate induction of these inflammatory mediators [2] .
It has been proposed that, in murine malaria, innate immune responses mediated by NK cells and/or gd T cells limit the initial phase of parasite replication [3] and that adaptive responses (mediated by ab T cells and B cells) are required for parasite elimination [4] . The difference between lethal and nonlethal malarial infections can be explained in part by the ability of mice to mount an early IL-12, interferon (IFN)-g, or TNF-a response [5] [6] [7] [8] . However, overproduction of IFN-g or TNF-a predisposes to severe pathology [8] [9] [10] , and neutralization of IL-12 or blockage of the IFN-g pathway decreases mortality [9, 11] . IL-4 is not essential to limiting cytokine-induced tissue damage [12, 13] , but mortality is higher among IL-10-deficient mice infected with Plasmodium chabaudi chabaudi AS than among their IL-10-sufficient littermates [14] . Importantly, down-regulation of TNF-a production and consequent resistance to severe malaria has been linked to the ability to produce the immunoregulatory cytokine transforming growth factor (TGF)-b [15] .
In humans, serum IFN-g levels have been correlated with resistance to reinfection with P. falciparum [16] , but plasma IFNg concentrations are higher in individuals with symptomatic than in individuals with asymptomatic infections [17] , and a temporal association between IFN-g secretion and fever has been seen in association with experimental malarial infections [18] . Similarly, increasing plasma TNF-a levels are associated with more rapid resolution of fever and parasite clearance [19, 20] , but severe P. falciparum malaria is accompanied by high levels of circulating TNF-a [21, 22] , and the severity of malaria ap- pears to be affected by the balance of proinflammatory to antiinflammatory cytokines in plasma [23] [24] [25] [26] [27] [28] . However, separating cause from effect is very difficult in cross-sectional studies of this kind.
Prospective studies of the relationship between the propensity for secretion of cytokines in response to antigen stimulation and subsequent risk that mild or severe and symptomatic or asymptomatic malaria will develop may provide a more robust test of the link between immune response and disease risk. Few such studies have been conducted in populations in malaria-endemic areas. A previous study showed that IFN-g production from peripheral blood mononuclear cells (PBMC) in response to soluble exoantigens of P. falciparum is associated with increased risk of clinical symptoms of malarial infection [29] . Luty et al. [30] demonstrated an association between IFN-g responses to defined liver-and blood-stage malaria antigens and subsequent resistance to reinfection [30] . To date, there are no prospective data on the relationship between malaria-specific induction of other proinflammatory cytokines and risk of malarial infection or disease or any data on the potential for modification of the outcome of infection by anti-inflammatory or immunoregulatory cytokines.
Our goal was to test the hypothesis that the development of clinical immunity to malaria in humans is associated with the ability to regulate the production of the proinflammatory cytokines IL-12, IFN-g, and TNF-a and that the anti-inflammatory cytokines TGF-b and/or IL-10 are a component of this process. We prospectively studied the association between malaria-specific cytokine production by PBMC in a whole blood assay (WBA) and susceptibility to symptomatic or asymptomatic malarial infection in a population in an area of holoendemic perennial malaria transmission in southern Ghana.
Subjects, Materials, and Methods
Study site, study design, and subjects. The study was conducted in the township of Dodowa in the coastal forest region of southern Ghana, where malaria transmission is perennial but where some seasonal variation is seen in the incidence of clinical cases [31] . Residents receive 20 infective mosquito bites per year; 98.5% of infections in humans are P. falciparum. Most of the population (95%) is of Ga or Ga-Adangbe origin; the remainder are of Ewe or Akan origin. For this study, we recruited 342 people aged 1.5-98 years, representing 65 compounds. Participating compounds were selected by random sampling from the 657 compounds in the township. Each person was given a full clinical examination, and examiners completed a health questionnaire for each subject. Ten milliliters of venous blood was collected from each individual (5 mL from children ,8 years old); 1 mL was stored in EDTA for hematologic examination, and the rest was placed in a heparinized container. A blood smear was prepared and examined for malaria parasites.
All subjects were monitored once a week for a 9-month period (April through December 2000) for signs of ill health. Field workers visited subjects at school or at home, completed a health questionnaire for each subject, measured each subject's axillary temperature, and collected a fingerprick blood sample from all subjects who were sick or febrile (axillary temperature > 37.5 C). Subjects with fever and malaria parasitemia were treated with chloroquine (25 mg/kg divided over the course of 3 days [i.e., 10 mg/kg on days 1 and 2 and 5 mg/kg on day 3]); those who failed to respond satisfactorily to chloroquine (~4% of all subjects who received treatment) received sulfadoxine pyrimethamine.
WBAs. Heparinized blood was diluted 1:10 with complete culture medium (RPMI 1640 medium with 100 IU/mL penicillin, 100 mg/mL streptomycin, and 2 mM L-glutamine) and distributed at 200 mL/well into sterile, round-bottomed 96-well microtiter plates, as described elsewhere [32] . Antigens or mitogens were added to replicate wells (20 mL/well), and plates were incubated at 37 C in 5% CO 2 . Malaria antigens included erythrocytes infected with live schizonts (10 4 live parasites [Lpar]/well), 10 4 intact uninfected erythrocytes/well, crude P. falciparum schizont extract (PfSE; equivalent to 10 4 schizonts/well) [33] , or uninfected erythrocyte extract (10 4 erythrocytes/well). Malaria parasites were derived from continuous cultures of the 3D7 clone of P. falciparum. Cultures were regularly tested by polymerase chain reaction and shown to be free of mycoplasma contamination. As a control for antigen-induced cytokine production, we used purified protein derivative (PPD) of Mycobacterium tuberculosis (10 mg/mL; Statens Serum Institute), and as a control for cell viability, we used the mitogen phytohemagglutinin (PHA; 5 mg/mL; Difco). At the end of the culture period, cell supernatants were collected and stored at 2 40 C. Cytokine assays. Supernatants were collected at 18 h for determination of levels of all cytokines except IFN-g, which was measured in 6-day supernatants for antigen-stimulated cells and 3-day supernatants for PHA-stimulated cells. IFN-g, TNF-a, IL-12, TGFb, and IL-10 were detected in culture supernatants by sandwich ELISA. All samples were tested in duplicate. Antibody pairs and standards were purchased from PharMingen or R&D Systems.
Data management and statistical analysis. Field data were entered in Dbase (Borland). We compiled cytokine response data by use of Excel software (Microsoft). All data were translated into Stata software (Stata Corp.) data and merged. To normalize the distribution of cytokine values, we performed a log e transformation. Pearson correlation coefficients were calculated for the transformed data to compare cytokine responses in antigen-stimulated and unstimulated cultures. We show antigen-specific cytokine responses as stimulation indices (SIs), and statistical analyses were performed by use of the log stimulation index (LSI) [34] . SI values were calculated using each stimulus and its relevant control (PHA and PPD vs. growth medium alone; Lpar vs. intact, uninfected erythrocytes; and PfSE vs. uninfected erythrocyte extract). We examined the relationship between log cytokine concentration or LSI and 4 outcomes: malaria parasitemia at recruitment, detection of >1 febrile episode during follow-up, incidence of clinical malaria (defined as temperature .37.5 C and parasitemia) during follow-up, and hemoglobin (Hb) concentration at recruitment.
For the first 3 outcomes, we used logistic regression analysis to compare subjects with and without each outcome. Hb concentration was analyzed as a continuous variable by linear regression analysis. All analyses were adjusted for potential confounding by age and white blood cell (WBC) count. To relate malaria outcome to cytokine response data, comparisons were made for 5 different antigens and 2 different transformations (log e cytokine concentration or LSI and cytokine ratios). Using the Bonferroni criterion to correct for multiple comparisons, we took P ¼ :005 (0.05/10) as the level for significant association between the outcome and the cytokine response [35] .
Results
Of the 342 persons from 65 different households who were recruited for the study, WBA data were obtained from 325. The majority of these 325 persons had lived in Dodowa for their entire lives (73%) or for > 5 years (94%). Table 1 shows subject ages, sex distribution, results of hematologic testing, recent medical history, and prevalence of signs and symptoms of clinical malaria at recruitment and during follow-up. Follow-up for evidence of malaria-related morbidity was conducted weekly for 9 months (37 weeks) for 301 subjects; 9294 (84%) of 11,137 potential follow-up visits were successfully completed.
Age-related changes in malariometric parameters. A positive association was seen between age and mean Hb concentration and between age and mean red blood cell count at recruitment, as is expected for a highly malaria-endemic community; these age trends were highly statistically significant. Again, as expected, there was a highly significant inverse association between age and prevalence of malaria parasitemia. Median positive parasite density also decreased with age, and reported symptoms that were compatible with a diagnosis of malaria (fever, headache, cough, and nausea) were significantly more common among children than among adults.
During follow-up, the prevalence of clinical symptoms compatible with a diagnosis of malaria was not significantly related to age, except that vomiting was more common among children and reported body pain was more common among adults. The incidence of documented clinical malaria was higher among subjects , 10 years old than among those >10 years old, but this difference was not statistically significant (6 of 79 subjects vs. 8 of 222 subjects, respectively; x 2 ¼ 2:09; P . :1). The number of clinical cases of malaria detected was, however, very small.
Age-related changes in immunologic parameters. The negative association between age and WBC count (table 1) was highly statistically significant; a gradual decline in WBC counts in association with increasing age is a normal feature in most populations. Because we used a WBA, we considered the possibility that cytokine production levels might be affected by leukocyte density. With the exception of IL-10 responses to live parasites, absolute concentrations of cytokine in culture supernatants were not significantly affected by the WBC count of the donor (data not shown), but mean SI values for IL-10, IFN-g, and TNF-a all increased significantly in association with increasing WBC counts. We therefore allowed for individual variation in WBC count in subsequent analyses.
The mean SI for antigen-induced cytokine responses was compared across age groups (table 2) . For Lpar-induced TNF-a and IFN-g, the mean SI in the 5 age groups differed significantly, but Table 1 . Demographic and clinical characteristics in the cohort of a study in Ghana of the relationship between malaria-related outcomes and cytokine production, at study recruitment and during follow-up, by age group. there was no significant age-related effect on SI values for TGFb, IL-10, or IL-12. For IFN-g, the trend was toward a decrease in mean SI for children and young adults; however, the mean SI increased again for older age groups. In contrast, for TNF-a, there was a statistically significant upward trend in mean SI in association with increasing age. The mean SI for Lpar-or PfSE-induced IL-10 was almost 1.0 for all age groups, indicating that little, if any, malaria-specific IL-10 was detectable in whole blood cultures.
Evidence for individual variations in baseline cytokine production potential. Interestingly, for all of the cytokines tested, there was a strong and highly statistically significant (P , :001, for all cases) correlation between cytokine concentrations in antigen-stimulated cultures and cytokine concentrations in the corresponding control cultures. This correlation was consistent across all age groups (data not shown), which suggests that baseline levels of cytokine production vary between persons. This may be indicative of individual genetic differences in cytokine regulation rather than reflecting prior exposure to infections that led to immune deviation. Despite this evidence for individual variation in innate ability to secrete certain cytokines, cells from many subjects clearly responded to specific antigen stimulation by secreting high levels of cytokine. Mean SI values were, in general, . 1.0 (table 2) .
TNF-a and IFN-g responses to Lpar were significantly correlated within persons (R ¼ 0:24; P , :001), and IL-12 responses to Lpar were strongly correlated with both IFN-g and TNF-a responses (R ¼ 0:31; P , :001, in both cases) but not with IL-10 or TGF-b responses. These observations support the notion that IL-12 drives the production of the proinflammatory cascade and that IFN-g drives TNF-a production (or that the 2 cytokines are coregulated) during a specific immune response. Interestingly, levels of Lpar-induced TNF-a were positively correlated with IL-10 levels (R ¼ 0:18; P , :001, for all cases), but there were no significant correlations between Lpar-induced TGF-b production and any of the other cytokines.
Association between cytokine production and indicators of susceptibility to malaria. We examined the relationship between baseline, mitogen-induced, and antigen-induced cytokine responses (expressed as absolute concentrations, in pg/mL, of cytokine for unstimulated cultures and as LSIs for antigen-or mitogen-stimulated responses) and 4 clinical outcomes: presence or absence of parasitemia at recruitment, Hb concentration at recruitment, risk of developing fever (of any cause), and risk of a clinical attack of malaria (fever and parasitemia) during the follow-up period (table 3) .
Lpar-induced IFN-g production was strongly and significantly associated with reduced risk of fever and with reduced risk of clinical malaria during follow-up. Parasite-specific IFNg responses were associated with a reduced risk of parasitemia at recruitment (not statistically significant). IFN-g responses were not significantly associated with Hb concentration. Neither background nor PHA-or PPD-induced levels of IFN-g were significantly associated with malaria outcomes. Production of TNFa in response to live parasites was associated with reduced risk of fever during follow-up. This association approached statistical significance. Baseline TNF-a responses were significantly and strongly associated with Hb concentration; each log e increase in TNF-a concentration was associated with a 0.2 g/dL increase in Hb. Background levels of IL-12 production were associated with a reduced risk of parasitemia at recruitment and were significantly associated with increased Hb concen- tration. PHA-and PPD-induced IL-12 levels were negatively associated with Hb. No association was seen between parasitespecific IL-12 induction and malaria outcomes.
IL-10 responses were very low in all whole blood cultures, and only 1 marginally significant association with the outcome parameters was observed. PHA-induced IL-10 was positively associated with Hb concentration. Finally, PHA-induced TGFb production was associated with a significantly reduced risk of fever.
Cytokine balance and malaria risk. Because the balance of pro-and anti-inflammatory cytokine responses during infection may be as important, if not more important, than absolute levels of any single cytokine, we compared the ratios of proinflammatory cytokines (IL-12, IFN-g, and TNF-a) to putatively anti-inflammatory cytokines (IL-10 and TGF-b) with malaria-related outcomes (table 4) . No significant associations were seen between cytokine ratios and the risk of clinical malaria, although this may well be because relatively few cases of clinical malaria were detected in our study. In contrast, high ratios of IFN-g, TNF-a, or IL-12 to TGF-b were consistently and significantly associated with increased risk of fever, whereas ratios of proinflammatory cytokines to either TGF-b or IL-10 were consistently correlated with increasing Hb concentration. These effects were not specific to malaria antigen-induced responses.
Discussion
Data from animal models of malaria clearly indicate that secretion of proinflammatory cytokines is essential to parasite NOTE. P values shown in bold remained significant after correction for multiple comparisons. Where P values are not given, P . :05. IFN, interferon; IL, interleukin; Lpar, live parasites; OR, odds ratio; PfSE, Plasmodium falciparum schizont extract; PHA, phytohemagglutinin; PPD, Mycobacterium tuberculosis purified protein derivative; TGF, transforming growth factor; TNF, tumor necrosis factor. a ORs show increased odds of disease outcome with each unit increase of the log of the cytokine production. b All cytokine data are log transformed. For control values, log concentration (pg/mL) is used; for all other values, log stimulation index is used. All associations were adjusted for age and white blood cell count.
c Regression coefficient shows increase in hemoglobin concentration (g/L) with each log increase in cytokine production.
Cytokine Production and Immunity to Malaria JID 2002;185 (1 April) clearance but that these inflammatory cytokines must be downregulated at the appropriate point in the infection to prevent pathology. The timing (and possibly the site) of cytokine release and the relative concentrations of opposing groups of cytokines contribute to successful resolution of the infection. Early IFN-g production, which may depend on appropriate induction of IL-12 or IL-18 from dendritic cells or macrophages [5, 36, 37] , appears to be a crucial component of the proinflammatory response, but it leads to up-regulation of TNF-a, which is believed to be the principle mediator of malaria pathology [22] . Almost inevitably, therefore, activation of parasite clearance mechanisms will predispose an individual toward clinical disease. The ability to effectively balance these 2 effects is a hallmark of clinical immunity to malaria.
Our studies of murine malaria [15] (F.M.O. and E.M.R., unpublished data) indicate that the principle immunoregulatory mechanism that allows parasite clearance to occur without overwhelming pathology is specific induction of TGF-b during the transition from the innate to the adaptive phase of the immune response (optimally occurring close to the time of peak parasite- NOTE. P values shown in bold remained significant after correction for multiple comparisons. Where no P value is shown, P . :05. IFN, interferon; IL, interleukin; Lpar, live parasites; OR, odds ratio; PfSE, Plasmodium falciparum schizont extract; PHA, phytohemagglutinin; PPD, Mycobacterium tuberculosis purified protein derivative; TGF, transforming growth factor; TNF, tumor necrosis factor.
a Cytokine ratios are expressed as the difference in the log stimulation index for the 2 cytokines. b ORs show increased odds of disease outcome with each unit increase of the log of the cytokine production. c All associations were adjusted for age and white blood cell count. Regression coefficient shows increase in hemoglobin concentration (g/L) with each log increase in cytokine ratio. mia, 5-7 days after infection). Severe malaria pathology occurs either when TGF-b is not induced [15] or when TGF-b is induced too early in the course of the infection, which results in down-regulation of the nascent inflammatory response and allows uncontrolled parasite growth (F.M.O. and E.M.R., unpublished data).
Many data on malaria in humans are from studies of plasma cytokine levels during acute malarial infections. Some data from studies in humans support the results of studies of murine malaria (e.g., the association of high plasma levels of TNF-a [21, 22, 26] and low plasma concentrations of TGF-b [26, 38] with increased disease severity). However, clinical studies have also produced some less expected findings. For example, plasma IL-10 concentrations are invariably high in malaria patients [39] . The highest levels occur in persons with cerebral malaria [40] , with hyperparasitemia [25] , or with fatal cases of malaria [25] , but high ratios of circulating TNF-a to IL-10 are associated with severe anemia [23, 24, 28] . It is equally surprising that low concentrations of circulating IL-12 (a potent inducer of proinflammatory responses) are linked to severe malaria [26] .
All of the studies cited above used simple ELISAs to measure cytokine protein concentrations in plasma. These studies do not provide any information about the biological activity of the cytokines or the relative concentrations of bioactive to inactive cytokine or tissue cytokine levels. We also do not know whether the changes in cytokine concentration are primary or secondary (e.g., whether IL-10 levels are raised in direct response to malarial infection or in response to dangerously high levels of TNF-a).
To overcome some of the limitations of cross-sectional clinical studies, we prospectively studied the relationship between cytokine production potential and the ability to resist malarial infection or clinical disease. We opted to use the WBA, rather than purified PBMC, for several reasons. The WBA uses much smaller volumes of blood, which is an important criterion when multiple antigens and multiple cytokines are to be screened and when samples are collected from small children. Also, manipulation and inadvertent activation of the cell population is much reduced, theoretically reducing background levels of cytokine release. Finally, WBA allows culture of cells in relatively physiologic conditions, including in the presence of specific antimalarial antibodies that may modify antigen availability and antigen presentation and in the presence of granulocytes and platelets that are important sources of chemokines and cytokines.
The WBA has been validated in a number of systems, most notably for mycobacterial antigens, and responses are broadly comparable with those obtained using PBMC assays [32] . We have further validated the WBA for a wide range of bacterial and viral antigens and obtained good correlation with PBMC assays (S. Struike and E. M. Riley, unpublished data). Interestingly, for malaria-naive donors, IFN-g responses to malaria antigens are lower in WBAs than in PBMC cultures from the same donors (S. Struike and E. M. Riley, unpublished data).
Experiments are under way to determine the reason for this difference. Although it is possible that the absolute levels of malaria-specific IFN-g (and possibly other cytokines) detected in this study are lower than would have been obtained with PBMC assays, mitogen-or antigen-specific cytokine induction was clearly detectable for all 5 cytokines.
The first finding of interest from this study is the very strong correlation between baseline cytokine production and cytokine responses to antigens and mitogens within a single donor. This may be indicative of individual genetic differences in cytokine regulation. There is already good evidence for functional polymorphism in the promoter region of the TNF-a gene [41] . Alternatively, these correlations may indicate the development of bias toward either Th1-like or Th2/Th3-like responses after exposure to a variety of infectious organisms. If so, we might expect correlations to increase with age and antigen exposure-but this is not the case. Thus, our working hypothesis is that there is strong genetic control over both baseline and induced cytokine levels.
The only malaria-specific associations between cytokine response and disease parameters were seen for IFN-g. High levels of malaria-specific IFN-g production were associated with reduced risk of developing fever or clinical malaria during follow-up. These findings are consistent with the expected results of a major antiparasitic effect of IFN-g. Interestingly, these effects were much more apparent for IFN-g responses to Lpar red blood cells than they were for responses to dead parasite material (PfSE). We have shown that early (innate) IFN-g responses to malaria antigens are markedly stronger for live than for dead parasites; both gd T cells and NK cells respond preferentially to live parasites [42] (K. Artavanis-Tsakonas and E. M. Riley, unpublished data), which raises the possibility that IFN-g is derived from these rapidly activated cell types (rather than from memory T cells) and may be responsible for the protective IFN-g response. This is an extremely significant finding: namely, that the protective immune response to malaria is induced by intact parasitized red blood cells rather than by soluble parasite antigen. This may have important implications for malaria vaccine design.
High ratios of TNF-a, IFN-g, and IL-12 to TGF-b were consistently found in this study in association with increased risk of fever during the follow-up period. These associations were not antigen specific, which indicates that malaria-specific T cells are not the primary regulators of cytokine production in a WBA and that the inherent tendency in humans toward secretion of cytokines from other cell types (e.g., dendritic cells, macrophages, granulocytes, or platelets) may play a significant role in determining the outcome of infection. Nonetheless, these data provide evidence in support of our initial hypothesis that regulation of the proinflammatory cytokine cascade by immunoregulatory cytokines such as TGF-b contributes to protection from malarial pathology.
The other consistent observation was the association between high ratios of proinflammatory to anti-inflammatory cytokines (both TGF-b and IL-10) and increasing Hb concentration. A log e (i.e., 2.7-fold) increase in cytokine ratio was associated with an increase in Hb of 0.2 g/dL, which indicates that the antiparasitic effects of the proinflammatory cytokines may also protect against anemia and that the beneficial effects of these cytokines in control of parasitemia outweigh any potentially deleterious effects they may have on erythropoiesis. These observations directly contradict the results of clinical studies in which high ratios of plasma TNF-a to plasma IL-10 were associated with hospital admission for severe anemia [23, 24] . The explanation for these contradictory findings is not immediately obvious, but this may be an example of the difficulty of separating cause and effect in cross-sectional studies.
In conclusion, this study demonstrates that the propensity of a person to secrete IL-12, IFN-g, and TNF-a is associated with protection against parasitemia, clinical malaria, and anemia but that a high ratio of these cytokines to the immunoregulatory cytokine TGF-b predisposes to fever. Understanding how the balance of these cytokines is regulated during a malarial infection may lead to novel approaches to immunotherapy and immunoprophylaxis.
